Transmission and spreading of tauopathy in transgenic mouse brain

Cited by (1,006)

Items 701–800 of 1,006

1. Antibody Therapeutics Targeting Aβ and Tau
   Gilbert Gallardo, David M. Holtzman · 2017 · Cold Spring Harbor Perspectives in Medicine
2. Tau-directed approaches for the treatment of Alzheimer’s disease: focus on leuco-methylthioninium
   Seripa, Davide, Solfrizzi, Vincenzo, Imbimbo, Bruno P., Daniele, Antonio, Santamato, Andrea, Lozupone, Madia, Zuliani, Giovanni, Greco, Antonio, Logroscino, Giancarlo, Panza, Francesco · 2016 · Expert Review of Neurotherapeutics
3. Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor
   Josephine Labus, Kian Röhrs, Jana Ackmann, Hristo Varbanov, Franziska E. Müller, Shaobo Jia, Kathrin Jahreis, Anna-Lena Vollbrecht, Malte Butzlaff, Yvonne Schill et al. · 2020 · Progress in Neurobiology
4. Calcium phosphatase calcineurin influences tau metabolism
   Celeste M M. Karch, Amanda T. Jeng, Alison Goate · 2012 · Neurobiology of Aging
5. Alternate Strategies of Hsp90 Modulation for the Treatment of Cancer and Other Diseases
   Gary E. L. Brandt, Brian S. J. Blagg · 2009 · Current Topics in Medicinal Chemistry
6. Prions: Beyond a Single Protein
   Alvin S. Das, Wen‐Quan Zou · 2016 · Clinical Microbiology Reviews
7. Tau secretion is correlated to an increase of Golgi dynamics
   Nguyen‐Vi Mohamed, Alexandre Desjardins, Nicole M. Leclerc · 2017 · PLoS ONE
8. The neuronal extracellular matrix restricts distribution and internalization of aggregated Tau-protein
   Suttkus, A., Holzer, M., Morawski, M., Arendt, T. · 2016 · Neuroscience
9. Tau follows principal axes of functional and structural brain organization in Alzheimer’s disease
   Julie Ottoy, Min Su Kang, Jazlynn Xiu Min Tan, Lyndon Boone, Reinder Vos de Wael, Bo‐yong Park, Gleb Bezgin, Firoza Zubeida Lussier, Tharick Ali Pascoal, Nesrine Rahmouni et al. · 2024 · Nature Communications
10. Yeast prions and human prion-like proteins: sequence features and prediction methods
    Sean M. Cascarina, Eric D. Ross · 2014 · Cellular and Molecular Life Sciences
11. Titration of biologically active amyloid–β seeds in a transgenic mouse model of Alzheimer's disease
    Rodrigo Morales, Javiera B Bravo-Alegria, Claudia A. Duran-Aniotz, Claudio A. Soto · 2015 · Scientific Reports
12. Inhibitory Act of Selenoprotein P on Cu+/Cu2+-Induced Tau Aggregation and Neurotoxicity
    Xiubo Du, Youbiao Zheng, Zhi Wang, Yijing Chen, Rui Zhou, Guo-Li Song, Jiazuan Ni, Qiong Liu · 2014 · Inorganic Chemistry
13. Long non‐coding RNA 00507/miRNA‐181c‐5p/TTBK1/MAPT axis regulates tau hyperphosphorylation in Alzheimer's disease
    Yan Yan, Hua Yan, Ying Teng, Qin Wang, Ping Yang, Le Zhang, Han Cheng, Siwen Fu · 2020 · The Journal of Gene Medicine
14. The role of amyloidogenic protein oligomerization in neurodegenerative disease
    Gregor P. Lotz, Justin A. Legleiter · 2013 · Journal of Molecular Medicine
15. Tauopathy contributes to synaptic and cognitive deficits in a murine model for Alzheimer’s disease
    Stancu, Ilie‐Cosmin, Ris, Laurence, Vasconcelos, Bruno, Marinangeli, Claudia, Goeminne, Léonie, Laporte, Vincent, Haylani, Laetitia E., Couturier, Julien, Schakman, Olivier, Gailly, Philippe et al. · 2014 · The FASEB Journal
16. Accelerating progress in induced pluripotent stem cell research for neurological diseases
    Daisuke Ito, Hideyuki Okano, Norihiro Suzuki · 2012 · Annals of Neurology
17. Passive Immunization in JNPL3 Transgenic Mice Using an Array of Phospho-Tau Specific Antibodies
    Cristina d’Abramo, Christopher M. Acker, Heidy T. Jimenez, Peter Davies · 2015 · PLoS ONE
18. Glycosaminoglycans, Protein Aggregation and Neurodegeneration
    Dulce Papy-García, Morin Christophe, Minh Bao Huynh, Fernando Siñeriz, Ludmilla Sissoëff, Julia Elisa Sepulveda-Diaz, Rita Raisman‐Vozari · 2011 · Current Protein and Peptide Science
19. Tau Spreading Mechanisms; Implications for Dysfunctional Tauopathies
    Almudena Fuster-Matanzo, Félix Hernández, Jesús Ávila · 2018 · International Journal of Molecular Sciences
20. C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43
    Takashi Nonaka, Masami Masuda‐Suzukake, Masato Hosokawa, Aki Shimozawa, Shinobu Hirai, Haruo Okado, Masato Hasegawa · 2018 · Human Molecular Genetics
21. Reactivated endogenous retroviruses promote protein aggregate spreading
    Liu, Shu, Heumüller, Stefanie-Elisabeth, Hossinger, André, Müller, Stephan A., Buravlova, Oleksandra, Lichtenthaler, Stefan F., Denner, Philip, Vorberg, Ina M. · 2023 · Nature Communications
22. NPT088 reduces both amyloid‐β and tau pathologies in transgenic mice
    Levenson, Jonathan M., Schroeter, Sally, Carroll, Jenna C., Cullen, Valerie, Asp, Eva, Proschitsky, Ming, Chung, Charlotte H.‐Y., Gilead, Sharon, Nadeem, Muhammad, Dodiya, Hemraj B. et al. · 2016 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
23. Perspectives on Primary Blast Injury of the Brain: Translational Insights Into Non-inertial Low-Intensity Blast Injury
    Heather R. Siedhoff, Shanyan Chen, Hailong Song, Jiankun Cui, Ibolja Černak, David X. Cifu, Ralph G. DePalma, Zezong Gu · 2022 · Frontiers in Neurology
24. Structure-based design of nanobodies that inhibit seeding of Alzheimer’s patient–extracted tau fibrils
    Romany N. N. Abskharon, Hope Pan, Michael R. Sawaya, Paul M. Seidler, Eileen J. Olivares, Yu Chen, Kevin A. Murray, Jeffrey Zhang, Carter Lantz, Megan Bentzel et al. · 2023 · Proceedings of the National Academy of Sciences
25. Brief update on different roles of tau in neurodegeneration
    Arne Ittner, Yazi Diana Ke, Janet van Eersel, Amadeus Gladbach, Jürgen Götz, Lars Matthias Ittner · 2011 · IUBMB Life
26. Intracerebral seeding of amyloid-β and tau pathology in mice: Factors underlying prion-like spreading and comparisons with α-synuclein
    Brendan B. McAllister, Sean G. Lacoursiere, Robert J. Sutherland, Majid H. Mohajerani · 2020 · Neuroscience & Biobehavioral Reviews
27. Dysregulation of Exosome Cargo by Mutant Tau Expressed in Human-induced Pluripotent Stem Cell (iPSC) Neurons Revealed by Proteomics Analyses
    Sonia Podvin, Alexander Curtis Jones, Qing Liu, Brent D. Aulston, Linnea Ransom, Janneca Ames, Gloria Shen, Christopher B. Lietz, Zhenze Jiang, Anthony John O’Donoghue et al. · 2020 · Molecular & Cellular Proteomics
28. From beta amyloid to altered proteostasis in Alzheimer’s disease
    Amalia Cecilia Bruni, Livia Bernardi, Carlo Gabelli · 2020 · Ageing Research Reviews
29. TDP-43 Prions
    Takashi Nonaka, Masato Hasegawa · 2017 · Cold Spring Harbor Perspectives in Medicine
30. The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer’s Disease
    Zizhen Si, Xidi Wang · 2020 · Journal of Alzheimer s Disease
31. Cross β-Sheet Conformation of Keratin 8 Is a Specific Feature of Mallory–Denk Bodies Compared With Other Hepatocyte Inclusions
    Vineet Mahajan, Therése Klingstedt, Rozalyn A. Simon, K. Peter R. Nilsson, Andrea Thueringer, Karl Kashofer, Johannes Haybaeck, Helmut Denk, Peter Michael Abuja, Kurt Zatloukal · 2011 · Gastroenterology
32. The FK506-binding protein FKBP52in vitroinduces aggregation of truncated Tau forms with prion-like behavior
    Julien Giustiniani, Kevin Guillemeau, Omar Dounane, Elodie Sardin, Isabelle Huvent, Alain Schmitt, Malika Hamdane, Luc Buée, Isabelle Landrieu, Guy M. Lippens et al. · 2015 · The FASEB Journal
33. Diverse Misfolded Conformational Strains and Cross-seeding of Misfolded Proteins Implicated in Neurodegenerative Diseases
    Kwang Hun Lim · 2019 · Frontiers in Molecular Neuroscience
34. Impaired tau–microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations
    Yuxing Xia, Zachary A. Sorrentino, Justin D. Kim, Kevin H. Strang, Cara J. Riffe, Benoit I. Giasson · 2019 · Journal of Biological Chemistry
35. Tau internalization: A complex step in tau propagation
    Jianfeng Zhao, Hongrong Wu, Xiao‐Qing Tang · 2021 · Ageing Research Reviews
36. siRNA drug delivery across the blood–brain barrier in Alzheimer's disease
    Muhammad Imran Sajid, Fahad Sultan Sheikh, Faiza Anis, Nourina Nasim, Rachita K. Sumbria, Surya M. Nauli, Rakesh Kumar Tiwari · 2023 · Advanced Drug Delivery Reviews
37. Prion-like propagation of cytosolic protein aggregates
    Carmen I. Nussbaum-Krammer, Hermann M. Schätzl, Ina Maja Vorberg · 2009 · Prion
38. Simulations of blood as a suspension predicts a depth dependent hematocrit in the circulation throughout the cerebral cortex
    Grant A Hartung, Claudia Vesel, Ryan Morley, Ali M. Alaraj, John G. Sled, David Kleinfeld, Andreas A. Linninger · 2018 · PLoS Computational Biology
39. Expanding spectrum of prion diseases
    Jacob I. Ayers, Nick A. Paras, Stanley B. Prusiner · 2020 · Emerging Topics in Life Sciences
40. Basal Forebrain Cholinergic Neurons: Linking Down Syndrome and Alzheimer’s Disease
    Jose L. Martinez, Matthew D. Zammit, Nicole R. West, Bradley T. Christian, Anita Bhattacharyya · 2021 · Frontiers in Aging Neuroscience
41. Transmission of amyloid-beta and tau pathologies is associated with cognitive impairments in a primate
    Suzanne Lam, Fanny Petit, Anne‐Sophie Hérard, Susana Boluda, Sabiha Eddarkaoui, Martine Guillermier, The Brain Bank Neuro-C. E. B. Neuropathology Network, Franck Letournel, Marie‐Laure Martin‐Négrier, Maxime Faisant et al. · 2021 · Acta Neuropathologica Communications
42. RNA induces unique tau strains and stabilizes Alzheimer’s disease seeds
    Amy N. Zwierzchowski-Zarate, Aydé Mendoza‐Oliva, Omar M. Kashmer, Josue E. Collazo-Lopez, Charles L. White, Marc I. Diamond · 2022 · Journal of Biological Chemistry
43. The prion-like transmission of tau oligomers via exosomes
    Noel A. Jackson, Marcos Jair Guerrero‐Munoz, Diana Laura Castillo‐Carranza · 2022 · Frontiers in Aging Neuroscience
44. TDP ‐43 in amyotrophic lateral sclerosis – is it a prion disease?
    Albert Christian Ludolph, Johannes Brettschneider · 2015 · European Journal of Neurology
45. G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
    An Phu Tran Nguyen, Guillaume Daniel, Pamela Valdés, Md. Shariful Islam, Bernard Laurent Schneider, Darren J. Moore · 2017 · Human Molecular Genetics
46. Recent developments with tau-based drug discovery
    Khalid Iqbal, Fei Liu, Cheng‐Xin Gong · 2018 · Expert Opinion on Drug Discovery
47. The Role of Antibodies and Their Receptors in Protection Against Ordered Protein Assembly in Neurodegeneration
    Taxiarchis Katsinelos, Benjamin J. Tuck, Aamir S. Mukadam, William A. McEwan · 2019 · Frontiers in Immunology
48. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain
    Jeanna M. Wheeler, Pamela J. McMillan, Timothy J. Strovas, Nicole F. Liachko, Alexandre Amlie‐Wolf, Rebecca L. Kow, Ronald L. Klein, Patricia Szot, Linda Robinson, Chris R. Guthrie et al. · 2019 · Science Translational Medicine
49. Picalm reduction exacerbates tau pathology in a murine tauopathy model
    Kunié Ando, Robert De Decker, Cristina Vergara, Zehra Yilmaz, Salwa Mansour, Valérie Suain, Kristel Sleegers, Marie-Ange de Fisenne, Sarah Houben, Marie‐Claude Potier et al. · 2020 · Acta Neuropathologica
50. Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer’s disease
    Garrett S. Gibbons, Soojung Kim, Qihui Wu, Dawn M. Riddle, Susan N. Leight, Lakshmi N. Changolkar, Hong Wei Xu, Emily S. Meymand, Mia O’Reilly, Bin Zhang et al. · 2020 · Molecular Neurodegeneration
51. Biaryl Amides and Hydrazones as Therapeutics for Prion Disease in Transgenic Mice
    Duo Lü, Kurt Giles, Zhe Li, Satish Rao, Elena Dolghih, Joel R. Gever, Michal Geva, Manuel Elepano, Abby Oehler, Clifford Bryant et al. · 2013 · Journal of Pharmacology and Experimental Therapeutics
52. Chaperoning shape-shifting tau in disease
    Bryan D. Ryder, Paweł M. Wydorski, Zhiqiang Hou, Łukasz A. Joachimiak · 2022 · Trends in Biochemical Sciences
53. Astrocytic uptake of neuronal corpses promotes cell‐to‐cell spreading of tau pathology
    Mothes, Tobias, Portal, Benjamin, Konstantinidis, Evangelos, Eltom, Khalid, Libard, Sylwia, Streubel-Gallasch, Linn, Ingelsson, Martin, Rostami, Jinar, Lindskog, Maria, Erlandsson, Anna · 2023 · Acta Neuropathologica Communications
54. The fluorescent pentameric oligothiophene pFTAA identifies filamentous tau in live neurons cultured from adult P301S tau mice
    Jack Brelstaff, Bernardino Ossola, Jonas J. Neher, Therése Klingstedt, K. Peter R. Nilsson, Michel Goedert, Maria Grazia Spillantini, Aviva M. Tolkovsky · 2015 · Frontiers in Neuroscience
55. Microstructural Changes across Different Clinical Milestones of Disease in Amyotrophic Lateral Sclerosis
    Francesca Trojsi, Giuseppina Caiazzo, Daniele Corbo, Giovanni Piccirillo, Viviana Cristillo, Cinzia Femiano, Teresa Ferrantino, Mario Cirillo, Maria Rosaria Monsurrò, Fabrizio Esposito et al. · 2015 · PLoS ONE
56. Oxidative Stress Modifies the Levels and Phosphorylation State of Tau Protein in Human Fibroblasts
    Alejandro Ibáñez-Salazar, Bernardo Bañuelos-Hernández, Ildefonso Rodríguez‐Leyva, Érika Chi-Ahumada, Elizabeth Monreal‐Escalante, María Esther Jiménez-Capdeville, Sergio Rosales‐Mendoza · 2017 · Frontiers in Neuroscience
57. Prion-like mechanisms in amyotrophic lateral sclerosis
    Jacob I. Ayers, Neil R. Cashman · 2018 · Handbook of clinical neurology
58. Mathematical synthesis of the cortical circulation for the whole mouse brain-part I. theory and image integration
    Andreas A. Linninger, Grant A Hartung, Shoale Badr, Ryan Morley · 2019 · Computers in Biology and Medicine
59. Lipopolysaccharide exposure in a rat sepsis model results in hippocampal amyloid-β plaque and phosphorylated tau deposition and corresponding behavioral deficits
    Ryan A. Kirk, Raymond P. Kesner, Liming Wang, Qi Wu, Rheal A. Towner, John M. Hoffman, Kathryn A. Morton · 2019 · GeroScience
60. Exosomal and vesicle‐free tau seeds—propagation and convergence in endolysosomal permeabilization
    Juan Carlos Polanco, Jürgen Götz · 2021 · FEBS Journal
61. The multifaceted role of WNT signaling in Alzheimer’s disease onset and age-related progression.
    Kostes, William W., Brafman, David A. · 2023 · Cells
62. Local structural preferences in shaping tau amyloid polymorphism
    Nikolaos N. Louros, Martin Wilkinson, Grigoria Tsaka, Meine Ramakers, Chiara Morelli, Teresa Garcia, Rodrigo U. Gallardo, Sam D’Haeyer, Vera Goossens, Dominique Audenaert et al. · 2024 · Nature Communications
63. The endolysosomal system in conventional and unconventional protein secretion
    Néel, Eloïse, Chiritoiu-Butnaru, Marioara, Fargues, William, Denus, Morgane, Colladant, Maëlle, Filaquier, Aurore, Stewart, Sarah E., Lehmann, Sylvain, Zurzolo, Chiara, Rubinsztein, David C. et al. · 2024 · Journal of Cell Biology
64. Global brain activity and its coupling with cerebrospinal fluid flow is related to tau pathology
    Feng Han, JiaQie Lee, Xi Chen, Jacob Ziontz, Tyler J. Ward, Susan M. Landau, Suzanne L. Baker, Theresa M. Harrison, William J. Jagust, Alzheimer’s Disease Neuroimaging Initiative · 2024 · Alzheimer s & Dementia
65. A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1
    Cristian A. Lasagna‐Reeves, Maxime W.C. Rousseaux, Marcos Jair Guerrero‐Munoz, Jeehye Park, Paymaan Jafar‐Nejad, Ronald Richman, Nan Lü, Urmi Sengupta, Alexandra Litvinchuk, Harry T. Orr et al. · 2015 · eLife
66. Recombinant Prion Protein Refolded with Lipid and RNA Has the Biochemical Hallmarks of a Prion but Lacks In Vivo Infectivity
    Andrew G. Timmes, Roger A. Moore, Elizabeth R. Fischer, Suzette A. Priola · 2013 · PLoS ONE
67. Initiation and propagation of neurodegeneration
    Christian Haass · 2010 · Nature Medicine
68. Early Structural and Functional Defects in Synapses and Myelinated Axons in Stratum Lacunosum Moleculare in Two Preclinical Models for Tauopathy
    Hervé Maurin, Seon‐Ah Chong, Igor Kraev, Heather A. Davies, Anna Kremer, Claire Marie Seymour, Benoit Lechat, Tomasz Jaworski, Peter Borghgraef, Herman Devijver et al. · 2014 · PLoS ONE
69. Chaperone-dependent Neurodegeneration: A Molecular Perspective on Therapeutic Intervention
    Aaron Carman Sarah Kishinevsky, John Koren III Wenjie Lou · 2013 · Journal of Alzheimer’s Disease & Parkinsonism
70. A Review of Treatment Options for Progressive Supranuclear Palsy
    María Stamelou, Günter U. Höglinger · 2016 · CNS Drugs
71. Differences in Aβ brain networks in Alzheimer's disease and healthy controls
    Huoqiang Duan, Jiehui Jiang, Jun Liang Xu, Hucheng Zhou, Zhemin Huang, Zhihua Yu, Zhuangzhi Yan · 2016 · Brain Research
72. A method for inferring regional origins of neurodegeneration
    Justin Torok, Pedro D. Maia, Fon Powell, Sneha Pandya, Ashish Raj · 2017 · Brain
73. Mechanism of aggregation and membrane interactions of mammalian prion protein
    Sabareesan Ambadi Thody, M.K. Mathew, Jayant B. Udgaonkar · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
74. Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
    Samantha De La‐Rocque, Edoardo Moretto, Ioana Butnaru, Giampietro Schiavo · 2020 · Journal of Neurochemistry
75. Understanding the Pathophysiological Actions of Tau Oligomers: A Critical Review of Current Electrophysiological Approaches
    Emily Hill, Mark John Wall, Kevin G. Moffat, Thomas K. Karikari · 2020 · Frontiers in Molecular Neuroscience
76. Deep Brain Stimulation for Alzheimer’s Disease: Tackling Circuit Dysfunction
    Jordan Lam, Justin Lee, Charles Yu Liu, Andrés M. Lozano, Darrin J. Lee · 2020 · Neuromodulation Technology at the Neural Interface
77. A local insult of okadaic acid in wild-type mice induces tau phosphorylation and protein aggregation in anatomically distinct brain regions
    Siân L. Baker, Jürgen Götz · 2016 · Acta Neuropathologica Communications
78. The Prion-Like Behavior of Assembled Tau in Transgenic Mice
    Florence Clavaguera, Markus Tolnay, Michel Goedert · 2016 · Cold Spring Harbor Perspectives in Medicine
79. Further understanding of tau phosphorylation: implications for therapy
    Medina, Miguel, Avila, Jesús · 2015 · Expert Review of Neurotherapeutics
80. Type-I Interferons in Alzheimer's Disease and Other Tauopathies
    Sophie Sanford, William A. McEwan · 2022 · Frontiers in Cellular Neuroscience
81. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer’s disease – Evidence from an MRI-based meta-analysis
    Marthe Mieling, Hannah Meier, Nico Bunzeck · 2023 · Neuroscience & Biobehavioral Reviews
82. Recent trends in treatment strategies for Alzheimer's disease and the challenges: A topical advancement
    Ni Liu, Xiaohan Liang, Yu Chen, Lihang Xie · 2024 · Ageing Research Reviews
83. Cerebrospinal Fluid Levels of a 20–22 kDa NH2 Fragment of Human Tau Provide a Novel Neuronal Injury Biomarker in Alzheimer's Disease and Other Dementias
    Giuseppina Amadoro, Veronica Corsetti, Giulia Maria Sancesario, Adele Lubrano, Gaia Melchiorri, Sergio Bernardini, Pietro Calissano, Giuseppe Sancesario · 2014 · Journal of Alzheimer s Disease
84. Is tau ready for admission to the prion club?
    Garth F. Hall, Brian A. Patuto · 2012 · Prion
85. Progressive supranuclear palsy
    Nikolaos Giagkou, Günter U. Höglinger, María Stamelou · 2019 · International review of neurobiology
86. Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice
    Isabelle Lavenir, Daniela Passarella, Masami Masuda‐Suzukake, Annabelle Curry, Janice L. Holton, Bernardino Francesco Ghetti, Michel Goedert · 2019 · Acta Neuropathologica Communications
87. Aβ Seeding as a Tool to Study Cerebral Amyloidosis and Associated Pathology
    Marina Friesen, Melanie Meyer‐Luehmann · 2019 · Frontiers in Molecular Neuroscience
88. Tau secretion and propagation: Perspectives for potential preventive interventions in Alzheimer's disease and other tauopathies
    Narendran Annadurai, Juan Bautista De Sanctis, Marián Hajdúch, Viswanath Das · 2021 · Experimental Neurology
89. Disruption of nuclear envelope integrity as a possible initiating event in tauopathies
    Marine Prissette, Wen Fury, Matthew Koss, Claudia Racioppi, Daria Fedorova, Ella Dragileva, Georgia Clarke, Taylor Pohl, John Dugan, Diana Ahrens et al. · 2022 · Cell Reports
90. Single cell transcriptomic profiling of a neuron-astrocyte assembloid tauopathy model
    Hannah Rickner, Lulu Jiang, Rui Hong, Nicholas K. O’Neill, Chromewell A. Mojica, Benjamin J. Snyder, Lushuang Zhang, Dipan Shaw, Maria Medalla, Benjamin L. Wolozin et al. · 2022 · Nature Communications
91. Interneurons in the human olfactory system in Alzheimer's disease
    Daniel Saiz‐Sánchez, Alicia Flores‐Cuadrado, Isabel Úbeda‐Bañón, Carlos de la Rosa‐Prieto, Alino Martı́nez-Marcos · 2015 · Experimental Neurology
92. A closer look at the mycobiome in Alzheimer’s disease: Fungal species, pathogenesis and transmission
    Phuna, Zhi Xin, Madhavan, Priya · 2022 · European Journal of Neuroscience
93. Reversibility of Tau-Related Cognitive Defects in a Regulatable FTD Mouse Model
    Astrid Sydow, Ann Van der Jeugd, Fang Zheng, Tariq Ahmed, Detlef Balschun, Olga M. Petrova, Dagmar Drexler, Lepu Zhou, Gabriele M. Rune, Eckhard Mandelkow� et al. · 2011 · Journal of Molecular Neuroscience
94. Wild-type Human γD-crystallin Promotes Aggregation of Its Oxidation-mimicking, Misfolding-prone W42Q Mutant
    Eugene Serebryany, Jonathan King · 2015 · Journal of Biological Chemistry
95. Rebels with a cause: molecular features and physiological consequences of yeast prions
    David M. Garcia, Daniel F. Jarosz · 2013 · FEMS Yeast Research
96. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice
    Mark K. Schultz, Renee C. Gentzel, Marija Usenovic, Cheryl A. Gretzula, C. Ware, Sophie Parmentier‐Batteur, Joel B. Schachter, Hatim A. Zariwala · 2018 · Neurobiology of Disease
97. Molecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
    Yuan Zhao, Yidan Zhang, Jian Zhang, Xiangjian Zhang, Guofeng Yang · 2020 · Current Neuropharmacology
98. Invited Review – Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials
    Delphine Boche, James A. R. Nicoll · 2020 · Neuropathology and Applied Neurobiology
99. PAC1 receptor–mediated clearance of tau in postsynaptic compartments attenuates tau pathology in mouse brain
    Ari W. Schaler, Avery M. Runyan, Catherine L. Taylor Clelland, Eric J. Sydney, Stephanie L. Fowler, Helen Y. Figueroa, Seiji Shioda, Ismael Santa‐María, Karen Duff, Natura Myeku · 2021 · Science Translational Medicine
100. Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
     Sun, Mingyue, Chen, Zhuoyou · 2024 · Journal of Inflammation Research